Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
2015 1
2016 2
2017 2
2018 1
2019 1
2020 1
2021 4
2022 2
2023 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Disparities in Utilization of Advanced Structural Heart Cardiovascular Therapies.
Goldsweig AM, Coylewright M, Daggubati R, Hermiller JB, Herrmann HC, Horne A, Khalil M, Shah B, Smith TBBJ, Szerlip M; SCAI 2022 Think Tank Structural Consortium; Buehler T, Cotton J, Evans J, Rudy J, Stivland TM. Goldsweig AM, et al. Among authors: stivland tm. J Soc Cardiovasc Angiogr Interv. 2023 Jan 4;2(1):100535. doi: 10.1016/j.jscai.2022.100535. eCollection 2023 Jan-Feb. J Soc Cardiovasc Angiogr Interv. 2023. PMID: 39132517 Free PMC article. No abstract available.
REPLY: Reshaping Patient Outcomes With Machine Learning.
Tereshchenko LG, Howell SJ, Stivland TM, Stein K, Ellenbogen KA. Tereshchenko LG, et al. Among authors: stivland tm. JACC Clin Electrophysiol. 2021 Dec;7(12):1623-1624. doi: 10.1016/j.jacep.2021.09.011. JACC Clin Electrophysiol. 2021. PMID: 34949428 Free PMC article. No abstract available.
Perioperative Safety and Early Patient and Device Outcomes Among Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Implantations : A Randomized, Multicenter Trial.
Healey JS, Krahn AD, Bashir J, Amit G, Philippon F, McIntyre WF, Tsang B, Joza J, Exner DV, Birnie DH, Sadek M, Leong DP, Sikkel M, Korley V, Sapp JL, Roux JF, Lee SF, Wong G, Djuric A, Spears D, Carroll S, Crystal E, Hruczkowski T, Connolly SJ, Mondesert B; ATLAS Investigators. Healey JS, et al. Ann Intern Med. 2022 Dec;175(12):1658-1665. doi: 10.7326/M22-1566. Epub 2022 Nov 8. Ann Intern Med. 2022. PMID: 36343346 Clinical Trial.
Device-related infection in de novo transvenous implantable cardioverter-defibrillator Medicare patients.
El-Chami MF, Jacobsen CM, Griffiths RI, Hansen LK, Wold N, Amorosi SL, Stivland TM, Knight BP, Weiss R, Mark GE, Biffi M, Probst V, Lambiase PD, Miller MA, Baddour LM. El-Chami MF, et al. Among authors: stivland tm. Heart Rhythm. 2021 Aug;18(8):1301-1309. doi: 10.1016/j.hrthm.2021.04.014. Epub 2021 Apr 19. Heart Rhythm. 2021. PMID: 33887452 Free article.
Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: Clinical characteristics and perioperative results.
Gold MR, Aasbo JD, El-Chami MF, Niebauer M, Herre J, Prutkin JM, Knight BP, Kutalek S, Hsu K, Weiss R, Bass E, Husby M, Stivland TM, Burke MC. Gold MR, et al. Among authors: stivland tm. Heart Rhythm. 2017 Oct;14(10):1456-1463. doi: 10.1016/j.hrthm.2017.05.016. Epub 2017 May 11. Heart Rhythm. 2017. PMID: 28502872 Free article. Clinical Trial.
14 results